Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2005
08/25/2005WO2005078094A2 Stabilized rnas as transfection controls and silencing reagents
08/25/2005WO2005078093A1 siRNA MOLECULE INHIBITING THE EXPRESSION OF PRION GENE
08/25/2005WO2005078092A1 Method of detecting and identifying gram-negative obligative anaerobic bacterium
08/25/2005WO2005078091A1 Induction of apoptosis by inhibition of sirtuin sirt1 expression
08/25/2005WO2005078090A2 Antisense oligonucleotides for treating unwanted pigmentation of the skin and hair
08/25/2005WO2005078089A1 Method for producing sirna molecules and sirna molecules produced therewith
08/25/2005WO2005078088A1 Mechanism of separating and purifying dna and so on
08/25/2005WO2005078087A1 Antibody targeting osteoclast-associated protein
08/25/2005WO2005078086A1 Method of detecting and identifying lactic acid bacterium
08/25/2005WO2005078084A1 Polyion complex carrying double stranded oligonucleic acid, process for producing the same and pharmaceutical composition containing the same
08/25/2005WO2005078083A1 Ultra-smooth microfabricated pores on a planar substrate for integrated patch-clamping
08/25/2005WO2005078082A1 Method of constructing probe dna for nucleic acid encoding membrane protein, method of detecting the expression of gene encoding membrane protein and probe dna immobilization support
08/25/2005WO2005078081A1 Use of compounds that regulate hdac6 tubulin deacetylase activity in the preparation of pharmaceutical compositions, method of identifying the aforementioned regulating compounds, said pharmaceutical compounds and applications thereof
08/25/2005WO2005078079A1 Phytate polynucleotides and methods of use
08/25/2005WO2005078077A2 Acid alpha-glucosidase and fragments thereof
08/25/2005WO2005078076A2 Tpl2 and its expression
08/25/2005WO2005078075A2 Hybrid proteins of active-site serine beta-lactamase
08/25/2005WO2005078069A1 Method for identifying cellular targets
08/25/2005WO2005077977A2 Carcinoembryonic antigen fusions proteins and uses thereof
08/25/2005WO2005077976A2 Coiled-coil domains from c4b-binding protein
08/25/2005WO2005077423A2 Adept or gdept producing acetaldehyde
08/25/2005WO2005077333A2 Gel-based delivery of recombinant adeno-associated virus vectors
08/25/2005WO2005077153A1 Bioreactor using viviparous plant
08/25/2005WO2005077126A2 Use of ppargamma specific inhibitors as anti-cancer therapeutics
08/25/2005WO2005077117A2 Transgenic corn seed with enhanced amino acid content
08/25/2005WO2005077116A2 Recombinant dna for gene suppression
08/25/2005WO2005077095A2 Ccn1 transgenic animals
08/25/2005WO2005077048A2 Immune modulation by regulating expression of the “minor” gene in immune dendritic cells
08/25/2005WO2005077042A2 Albumin fusion proteins
08/25/2005WO2005077022A2 Compositions and methods for modifying the content of polyunsaturated fatty acids in biological cells
08/25/2005WO2005076999A2 Methods and compositions for combination rnai therapeutics
08/25/2005WO2005076979A2 Diagnosis and therapeutics for cancer
08/25/2005WO2005076786A2 Colon carcinoma related oligonucleotides and methods of use
08/25/2005WO2005076766A2 Transient production of pharmaceutically important proteins in plants
08/25/2005WO2005076732A2 Peptide-pna chimera targeting inducible nitric oxide synthase
08/25/2005WO2005065707A3 Recombinant vaccine against japanese encephalitis virus [jev] infection and a method thereof
08/25/2005WO2005063816A3 Monovalent antibody fragments useful as therapeutics
08/25/2005WO2005061716A3 Expression vector used for antibiotic-free expression
08/25/2005WO2005059562A3 Diagnostic and therapeutic use of the human hif3alpha gene and proteins for neurodegenerative diseases
08/25/2005WO2005054265A3 Polyketides and their synthesis
08/25/2005WO2005051991A3 Mucin antigen vaccine
08/25/2005WO2005047537A3 Diagnosis of distal hereditary motor neuropathy type ii by detection of hsp22 gene polymorphisms
08/25/2005WO2005042777A3 App/ena antisense
08/25/2005WO2005041656A3 Methods, compositions and devices for inducing stasis in tissues and organs
08/25/2005WO2005039291A3 Methods, compositions and devices for inducing stasis in cells
08/25/2005WO2005035771A3 Nucleic acid constructs
08/25/2005WO2005033319A3 Stacking crop improvement traits in transgenic plants
08/25/2005WO2005033134A3 Secreted protein therapeutics and uses thereof
08/25/2005WO2005030982A3 Coordinated decrease and increase of gene expression of more than one gene using transgenic constructs
08/25/2005WO2005028615A3 Methods and compositions for detecting promoter activity and expressing fusion proteins
08/25/2005WO2005021585B1 Axmi-003, a delta-endotoxin gene and methods for its use
08/25/2005WO2005007829A3 Materials and methods for the modulation of cyclin-dependent kinase inhibitor-like polypeptides in maize
08/25/2005WO2005007827A3 Avian adeno-associated virus vector
08/25/2005WO2005005635A3 Antibodies against insulin-like growth factor i receptor and uses thereof
08/25/2005WO2004113500A3 B7s1: an immune modulator
08/25/2005WO2004101754A3 Plan regulatory sequences for selective control of gene expression
08/25/2005WO2004093820A3 Methods and compositions for solid tumor treatment
08/25/2005WO2004079331A3 Composition and method for immobilizing a substance on a solid-phase support
08/25/2005WO2003064621A3 HIGH POTENCY siRNAS FOR REDUCING THE EXPRESSION OF TARGET GENES
08/25/2005US20050188443 To produce celery plant having herbicide resistance; insect resistance
08/25/2005US20050188442 Method for altering storage organ composition
08/25/2005US20050188440 Nucleotide sequences coding insect hemolymph polypeptide for use in generating disease resistant plants; microbiocides; biological pest control
08/25/2005US20050188439 Methods for enhancing insect resistance in plants
08/25/2005US20050188438 Compositions and methods using rna interference for control of nematodes
08/25/2005US20050188436 Continuous culture of conifer embryogenic tissue
08/25/2005US20050188435 Method of increasing the GGT activity in plants, plants with increased GGT activity, and a method of producing such plants
08/25/2005US20050188434 Method for plant breeding
08/25/2005US20050188433 Expression vector comprising nucleotide sequences coding succinate/fumarate-transport protein for use generating and propagating plants with enhanced germination behavior
08/25/2005US20050188432 Enhancing transcription via TATA Box census element as core of promoter
08/25/2005US20050188431 Recombinant chicken comprising vector which codes and expresses erythropoietin and interferon in oviduct tissue; bioreactor and heterologous gene expression
08/25/2005US20050188430 Transgenic avians and protein production
08/25/2005US20050188429 Method for treating a condition with a cytokine of the GP130 subunit signaling family linked to a polynucleotide encoding SOCS-3
08/25/2005US20050188428 Method for generating hypermutable organisms
08/25/2005US20050188426 Transgenic zebrafish for use as animal model in identifying modulators of heart function
08/25/2005US20050187716 Three-dimensional model of a Fc region of an IgE antibody and uses thereof
08/25/2005US20050187380 Method for treating Th2-mediated disease
08/25/2005US20050187379 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/25/2005US20050187378 nucleotide sequences encoding oligopeptide sequences which can render fusion partner proteins environmental stress resistant by binding thereto while conserving their intrinsic properties; recombinant vectors, and cells transformed by them
08/25/2005US20050187180 Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA
08/25/2005US20050187179 treatment of tumors which have increased Notch expression; administration of either Notch antisense oligonucleotides or monoclonal antibodies directed to Notch along with cell differentiating agent
08/25/2005US20050187177 chimeric gene construct composed of a COX-2 promoter operably linked to at least one apoptosis-inducing gene that can cause selectively induced apoptosis in a population of diseased cells; entire classes of cells can be treated with one transfection
08/25/2005US20050187176 Method for inhibiting NF-kappa B signaling and use to treat or prevent human diseases
08/25/2005US20050187174 RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA)
08/25/2005US20050187161 peptide sequences that selectively bind to fungal surface molecules; Biopanning and Rapid Analysis of Selective Interactive Ligands (BRASIL) provides for rapid and efficient separation of phage that bind to fungal surface molecules
08/25/2005US20050186677 Novel mutated mammalian cells and animals
08/25/2005US20050186676 A strain of host cells that contains a temperature sensitive variant of the gene encoding the endonuclease VII from phage T4; a cloning method that selects for PCR products that are devoid of PCR-generated mutations
08/25/2005US20050186675 Allelic series of genomic modifications in cells
08/25/2005US20050186670 Method of detecting error spot in DNA chip and system using the method
08/25/2005US20050186666 Protein expression systems
08/25/2005US20050186665 Expressed ligand - vascular intercellular signaling molecule
08/25/2005US20050186664 Albumin fusion proteins
08/25/2005US20050186663 Cystine-knot fold protein
08/25/2005US20050186662 Follicle stimulating hormone-immunoglobulin fusion fo use in treatment of reproductive disorders
08/25/2005US20050186661 Via peptone iv derived from soybean, supplemented with corn steep liquor, beef extract, tryptone, casein, and gelatin; bacteriocin-release-proteins; tolerant to leucine, cysteine, arginine, glycine, asparagine (BDH) and aspartic acid; heat treatment; freeze drying; for use in detergents
08/25/2005US20050186660 Using calcitonin precursor protein as diagnostic tool in detection of cancer and sepsis
08/25/2005US20050186659 Methods for protein purification
08/25/2005US20050186658 Chimeric metabotropic glutamate receptors and uses thereof
08/25/2005US20050186654 Contacting L-alanine methyl ester as carboxy component and L-glutamine as amine component to an enzyme (E. coli JM 109) which catalyzes hydrolysis of amino acid ester to form a dipeptide; enzyme derived from a microorganism belonging to the genus Acetobacter
08/25/2005US20050186650 Pharmaceuticals and methods for treating hypoxia and screening methods therefor
08/25/2005US20050186649 Inhibitors of human plasmin derived from the kunitz domains